Fonseca, L., Paredes, S., Ramos, H., Oliveira, J. C., & Palma, I. (2020). Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
Referência de acordo com a norma ChicagoFonseca, Liliana, Sílvia Paredes, Helena Ramos, José Carlos Oliveira, e Isabel Palma. Apolipoprotein B and Non-high-density Lipoprotein Cholesterol Reveal a High Atherogenicity in Individuals With Type 2 Diabetes and Controlled Low-density Lipoprotein-cholesterol. 2020.
Referência de acordo com a norma MLAFonseca, Liliana, et al. Apolipoprotein B and Non-high-density Lipoprotein Cholesterol Reveal a High Atherogenicity in Individuals With Type 2 Diabetes and Controlled Low-density Lipoprotein-cholesterol. 2020.